Combined carvacrol and cilostazol ameliorate ethanol-induced liver fibrosis in rats: Possible role of SIRT1/Nrf2/HO-1 pathway.

MLA

Abu-Risha, Sally E., et al. “Combined Carvacrol and Cilostazol Ameliorate Ethanol-Induced Liver Fibrosis in Rats: Possible Role of SIRT1/Nrf2/HO-1 Pathway.” International Immunopharmacology, vol. 116, Mar. 2023, p. 109750. EBSCOhost, https://doi.org/10.1016/j.intimp.2023.109750.

APA

Abu-Risha, S. E., Sokar, S. S., Elbohoty, H. R., & Elsisi, A. E. (2023). Combined carvacrol and cilostazol ameliorate ethanol-induced liver fibrosis in rats: Possible role of SIRT1/Nrf2/HO-1 pathway. International Immunopharmacology, 116, 109750. https://doi.org/10.1016/j.intimp.2023.109750

Chicago

Abu-Risha, Sally E, Samia S Sokar, Heba R Elbohoty, and Alaa E Elsisi. 2023. “Combined Carvacrol and Cilostazol Ameliorate Ethanol-Induced Liver Fibrosis in Rats: Possible Role of SIRT1/Nrf2/HO-1 Pathway.” International Immunopharmacology 116 (March): 109750. doi:10.1016/j.intimp.2023.109750.